These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21518968)

  • 1. Notch3 is essential for regulation of the renal vascular tone.
    Boulos N; Helle F; Dussaule JC; Placier S; Milliez P; Djudjaj S; Guerrot D; Joutel A; Ronco P; Boffa JJ; Chatziantoniou C
    Hypertension; 2011 Jun; 57(6):1176-82. PubMed ID: 21518968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically increased angiotensin I-converting enzyme alters peripheral and renal vascular reactivity to angiotensin II and bradykinin in mice.
    Chollet C; Placier S; Chatziantoniou C; Hus-Citharel A; Caron N; Roussel R; Alhenc-Gelas F; Bouby N
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H350-H358. PubMed ID: 29101168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries.
    Belin de Chantemèle EJ; Retailleau K; Pinaud F; Vessières E; Bocquet A; Guihot AL; Lemaire B; Domenga V; Baufreton C; Loufrani L; Joutel A; Henrion D
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2216-24. PubMed ID: 18818417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Notch3 Impairs Contractility of Renal Resistance Vessels Due to Deficient Ca
    Helle F; Hultström M; Kavvadas P; Iversen B; Chadjichristos CE; Chatziantoniou C
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
    J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response.
    Kawada N; Dennehy K; Solis G; Modlinger P; Hamel R; Kawada JT; Aslam S; Moriyama T; Imai E; Welch WJ; Wilcox CS
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F753-9. PubMed ID: 15213069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice.
    Lai EY; Solis G; Luo Z; Carlstrom M; Sandberg K; Holland S; Wellstein A; Welch WJ; Wilcox CS
    Hypertension; 2012 Feb; 59(2):415-20. PubMed ID: 22184329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compromised renal microvascular reactivity of angiotensin type 1 double null mice.
    Park S; Bivona BJ; Harrison-Bernard LM
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F60-7. PubMed ID: 17409281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated renovascular constrictor responses to angiotensin II in adenosine 1 receptor knockout mice.
    Hansen PB; Hashimoto S; Briggs J; Schnermann J
    Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R44-9. PubMed ID: 12793993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion.
    Sparks MA; Stegbauer J; Chen D; Gomez JA; Griffiths RC; Azad HA; Herrera M; Gurley SB; Coffman TM
    J Am Soc Nephrol; 2015 Dec; 26(12):2953-62. PubMed ID: 25855778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.
    Thai TL; Arendshorst WJ
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F169-76. PubMed ID: 19403649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice.
    Hercule HC; Tank J; Plehm R; Wellner M; da Costa Goncalves AC; Gollasch M; Diedrich A; Jordan J; Luft FC; Gross V
    Exp Physiol; 2007 Nov; 92(6):1014-22. PubMed ID: 17644703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term intrarenal angiotensin II infusion on renal vascular responsiveness to vasoactive agents.
    Fitzgerald SM; Stevenson KM; Evans RG; Anderson WP
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):633-6. PubMed ID: 9673443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.
    Bergaya S; Faure S; Baudrie V; Rio M; Escoubet B; Bonnin P; Henrion D; Loirand G; Achard JM; Jeunemaitre X; Hadchouel J
    Hypertension; 2011 Sep; 58(3):439-45. PubMed ID: 21768522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-Induced Hypertension Is Attenuated by Reduction of Sympathetic Output in NO-Sensitive Guanylyl Cyclase 1 Knockout Mice.
    Broekmans K; Stegbauer J; Potthoff SA; Russwurm M; Koesling D; Mergia E
    J Pharmacol Exp Ther; 2016 Jan; 356(1):191-9. PubMed ID: 26559126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
    Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
    Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of connexin40 in the autoregulatory response of the afferent arteriole.
    Sorensen CM; Giese I; Braunstein TH; Brasen JC; Salomonsson M; Holstein-Rathlou NH
    Am J Physiol Renal Physiol; 2012 Sep; 303(6):F855-63. PubMed ID: 22811484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.
    El Machhour F; Keuylian Z; Kavvadas P; Dussaule JC; Chatziantoniou C
    J Am Soc Nephrol; 2015 Jul; 26(7):1561-75. PubMed ID: 25421557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency.
    Brown NJ; Bradford J; Wang Z; Lea W; Ma L; Ma J; Vaughan DE; Fogo AB
    Kidney Int; 2007 Jul; 72(1):72-81. PubMed ID: 17429342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors.
    Hansen PB; Hashimoto S; Oppermann M; Huang Y; Briggs JP; Schnermann J
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1150-7. PubMed ID: 16120812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.